V. Mittoux

Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies

F. Condé, E. Brouillet, P. Hantraye, 2000, Neuroscience.

Serial 1H-NMR Spectroscopy Study of Metabolic Impairment in Primates Chronically Treated with the Succinate Dehydrogenase Inhibitor 3-Nitropropionic Acid

M. Beal, F. Condé, G. Bloch, 1999, Neurobiology of Disease.

Partial Inhibition of Brain Succinate Dehydrogenase by 3‐Nitropropionic Acid Is Sufficient to Initiate Striatal Degeneration in Rat

F. Condé, S. Palfi, E. Brouillet, 1998, Journal of neurochemistry.

Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease

Françoise Condé, Philippe Hantraye, Marc Peschanski, 1998, Nature Medicine.

Corticostriatopallidal Neuroprotection by Adenovirus-Mediated Ciliary Neurotrophic Factor Gene Transfer in a Rat Model of Progressive Striatal Degeneration

M. Peschanski, F. Condé, F. Lisovoski, 2002, The Journal of Neuroscience.

Replicating Huntington Disease’s Phenotype in Nonhuman Primates

F. Condé, S. Palfi, E. Brouillet, 2000 .

Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease.

J. Bloch, P. Hof, E. Nimchinsky, 2000, Human gene therapy.